Mechanisms of prescription drug diversion among drug-Involved club- and street-based populations

Pain Medicine

Volumn 8, Issue 2, 2007, Pages 171-183

  Inciardi, James A ^a   Surratt, Hilary L ^a   Kurtz, Steven P ^a   Cicero, Theodore J ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Opioids; Pain Medication; Prescription Drug Abuse; Prescription Drug Diversion

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; CANNABIS; COCAINE; CODEINE; DIAMORPHINE; DIAZEPAM; EFAVIRENZ; HYDROCODONE; HYDROMORPHONE; ILLICIT DRUG; METHADONE; METHAMPHETAMINE; METHYLPHENIDATE; MORPHINE; OPIATE; OXYCODONE; PAROXETINE; PHENTERMINE; QUETIAPINE; RITONAVIR; SERTRALINE; SILDENAFIL;

ADULT; ADVERTIZING; ARTICLE; CENTRAL AMERICA; CONTROLLED STUDY; DRUG ABUSE; DRUG COST; DRUG DEPENDENCE; DRUG MANUFACTURE; DRUG MARKETING; DRUG TRAFFIC; FEMALE; FORGERY; FRIEND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTERNET; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL DISEASE; MEXICO; PARENTAL BEHAVIOR; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; PRESCRIPTION; RELATIVE; SOUTH AMERICA; TELEPHONE; THEFT; UNITED STATES;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; ANALGESICS, OPIOID; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COCAINE-RELATED DISORDERS; CRACK COCAINE; CULTURE; DRUG INDUSTRY; FEMALE; FLORIDA; FOCUS GROUPS; HALLUCINOGENS; HEROIN DEPENDENCE; HIV SEROPOSITIVITY; HUMANS; MALE; METHADONE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PATIENTS; PHARMACY; PHYSICIANS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; STREET DRUGS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 33846988964     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2006.00255.x     Document Type: Article

References (90)

1. Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse 2006; 41: 1-10.
2. Inciardi JA, Goode JL. OxyContin and prescription drug abuse. Consumers Res 2003; 86(7): 17-21.
3. Meier B. Pain Killer: A "Wonder" Drug's Trail of Addiction and Death. Emmaus, PA: Rodale Press; 2003.
4. Nagel LM, Good PM. DEA-Industry Communicator Oxycontin Special. Washington, DC: U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control; 2001.
5. National Institute on Drug Abuse. Prescription Drugs: Abuse and Addiction. Bethesda, MD: NIDA Research Report Series; 2001. NIH publication 01-4881.
6. Thompson CA. Prescription drug misuse highlighted as national problem. Am J Health Syst Pharm 2001; 58: 956, 60.
7. Zacny J, Bigelow G, Compton P, et al. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug Alcohol Depend 2003; 69(3): 215-32.
8. National Drug Satety Network. Prescription drug abuse rivals illicit drug abuse. Some see double standard in law enforcement. News Briefs - Drug use Trends. Available at: http://www.ndsn.org/oct96/prescrip.html. Accessed December 6, 2006.
9. U.S. General Accounting Office. Oxycontin Abuse and Diversion and Efforts to Address the Problem [Report to Congressional Requesters, #GAO-04-110]. Washington, DC: U.S. Government Printing Office; 2003, December.
10. Weathermon RA. Controlled substances diversion: Who attempts it and how. US Pharm 1999; 24(12): 32-47.
11. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004; 28(2): 176-88.
12. Forgione DA, Neuenschwander P, Vermeer TE. Diversion of prescription drugs to the black market: What the states are doing to curb the tide. J Health Care Finance 2001; 27(4): 65-78.
13. Chandra A, Ozturk A. Health professionals beware of prescription pain medication abuse and diversion. Hosp Top 2004; 82(4): 34-7.
14. Inciardi JA. Prescription Drug Diversion. Paper presented at: Opioid Risk Management Conference; March 29, 2005; Boston, MA.
15. Inciardi JA, Surratt HL. Research Issues and Experiences in Studying Prescription Drug Diversion. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
16. Valdez A, Cepeda A, Kaplan CD, Yin Z. The legal importation of prescription drugs into the United States from Mexico: A study of customs declaration forms. Subst Use Misuse 1998; 33(12): 2485-97.
17. Valdez A, Sifaneck SJ. Drug tourists and drug policy on the U.S.-Mexican border: An ethnographic investigation of the acquisition of prescription drugs. J Drug Issues 1997; 27(4): 879-97.
18. Haddox JD. The Standards for Risk Management Plans for High Abuse Potential Medications. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
19. Leiderman DB. Prescription Drugs and the Risks of Abuse, Addiction, and Overdose: Regulatory Challenges. College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; 2005; North Bethesda, MD.
20. CASA (The National Center on Addiction and Substance Abuse at Columbia University). "You've Got Drugs!": Prescription Drug Pushers on the Internet [a CASA White Paper]. New York: Author; 2004, February.
21. Volkow ND. Priorities in Prescription Drug Abuse Research. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
22. Bergman U, Dahl-Puustinen M-L. Use of prescription forgeries in a drug abuse surveillance network. Eur J Clin Pharmacol 1989; 36: 621-3.
23. Blumenschein K. Prescription drug diversion: Fraudulent tactics utilized in the community pharmacy. Am J Pharm Educ 1997; 61: 184-8.
24. Borsack S. Hospital drug diversion: The verdict is in. Health Matrix 1986-1987; 4(4): 27-31.
25. Cooper JR, Czechowicz DJ, Petersen RC, Molinari SP. Prescription drug diversion control and medical practice. J Am Med Assoc 1992; 268(10): 1306-10.
26. McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse 2004; 39(7): 1095-116.
27. Simoni-Wastila L, Tompkins C. Balancing diversion control and medical necessity: The case of prescription drugs with abuse potential. Subst Use Misuse 2001; 36(9& 10): 1275-96.
28. Wilford BB, Finch J, Czechowicz DJ, Warren D. An overview of prescription drug misuse and abuse: Defining the problem and seeking solutions. J Law Med Ethics 1994; 22(3): 197-203.
29. Adams EH. Risk Management Action Plans for Opioids Now and in the Future. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
30. Cone EJ. Ephemeral Profiles of Prescription Drug Tampering: Evolving Pseudoscience on the Internet. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
31. McCormick CG. Regulatory Challenges for New Formulations in Today's Environment. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
32. Sapienza FL. Abuse Resistant Formulations and the Controlled Substances Act. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
33. Schuster CR. History and Current Perspectives on the Use of Drug Formulations to Decrease the Abuse of Prescription Drugs. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
34. Smith MY. Measuring Rates of Nonmedical Use-Dimensions and Denominators. Paper presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference; April 19-20, 2005; North Bethesda, MD.
35. U.S. Drug Enforcement Administration. DEA Unveils International Toll-Free Hotline to Report Illegal Prescription Drug Sales and Rogue Pharmacies Operating on the Internet. Available at: http://www.usdoj.gov/ dea/pubs/pressrel/pr121504.html (accessed January 25, 2005).
36. Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002-2004. Pain 2005; 6(10): 662-72.
37. Inciardi JA, Surratt HL. Trends in the Diversion of Prescription Drugs. Paper presented at: CPDD 68th Annual Scientific Meeting; June 17-22, 2006; Scottsdale, AZ.
38. Leap WL. Word's Out: Gay Men's English. Minneapolis, MN: University of Minnesota Press; 1996.
39. Miles MB, Huberman M. Qualitative Data Analysis. Thousand Oaks, CA: Sage Publications; 1994.
40. Charmaz K. Grounded theory: Objectivist and constructivist methods. In: Denzin NK, Lincoln YS, eds. Handbook of Qualitative Research, 2nd edition. Thousand Oaks, CA: Sage Publications; 2000: 509-35.
41. Glaser BG, Strauss AL. Discovery of Grounded Theory: Strategies for Qualitative Research. Hawthorne, NY: Walter de Guyter; 1967.
42. Kurtz SP. Prescription drug abuse among ecstasy users in Miami: Qualitative research findings. Epidemiologic Trends in Drug Abuse, Advance Report: Prescription Drug Abuse Community Epidemiology Work Group, June 2004. NIH Publication No. 04-5363A, Rockville, MD, The Institute, November 2004; 2004:43-7.
43. Kurtz SP, Inciardi JA, Surratt HL, Cottler L. Prescription drug abuse among ecstasy users in Miami. J Addict Dis 2005; 24(4): 1-16.
44. Griffith J. A study of illicit amphetamine drug traffic in Oklahoma City. Am J Psychiatry 1966; 123: 560-9.
45. Kramer JC, Fischman VS, Littlefield DC. Amphetamine abuse. Pattern and effects of high doses taken intravenously. J Am Med Assoc 1967; 201: 305-9.
46. Chambers CD, Brill L, Inciardi JA. Barbiturate use, misuse, and abuse. J Drug Issues 1972; 2: 15-20.
47. U.S. General Accounting Office. Retail Diversion of Legal Drugs-A Major Problem with No Easy Solution [Report to the Congress by the Comptroller General of the United States: DEA Report #GGD-78-22 Issued March 10, 1978]. Washington, DC: U.S. Government Printing Office; 1978.
48. Inciardi JA, Petersen DM, Chambers CD. Methaqualone abuse patterns, diversion paths and adverse reactions. J Fla Med Assoc 1974; 61: 279-83.
49. U.S. Congress, Senate and Subcommittee to Investigate Juvenile Delinquency of the Committee on the Judiciary. Legislative Hearings on the Methaqualone Control Act of 1973, S. 1252. Washington, DC: U.S. Government Printing Office; 1973.
50. Chambers CD, Inciardi JA, Stephens RC. A critical review of pentazocine abuse. HSMHA Health Rep 1971; 86(7): 627-36.
51. Goldman FR, Thistel CI. Diversion of methadone: Illicit methadone use among applicants to two metropolitan drug abuse programs. Int J Addict 1978; 13(6): 855-62.
52. Inciardi JA. Methadone Diversion: Experience and Issues. NIDA Services Research Monograph, DHEW Pub. No. (ADM) 77-488. Rockville, MD: National Institute on Drug Abuse; 1977.
53. Resnick RB. Problems of methadone diversion and implications for control. Int J Addict 1977; 12(7): 803-6.
54. Chambers CD, Inciardi JA. An Assessment of Drug Use in the General Population. Albany, NY: New York State Narcotic Addiction Control Commission; 1971.
55. Chambers CD, Brill L. Methadone: Experiences and Issues. New York City: Behavioral Publications; 1973.
56. Weppner RS, Stephens RC. The illicit use and diversion of methadone on the street as related by hospitalized addicts. J Drug Issues 1973; 3 (Winter): 111-5.
57. Inciardi JA. Careers in Crime. Chicago, IL: Rand McNally College Publishing Company; 1975.
58. Bureau of Justice Statistics. Criminal Victimization in the United States, 2004. Washington, DC: Author; 2005.
59. Associated Press. Miami Man Gets Prison Time for Illegally Selling Pharmaceuticals. Available at: LexisNexis Academic database (accessed May 31, 2005).
60. Breister P. Area authorities on alert after home invasions. Reporter 2005: 04A.
61. Gedan B. Despite 2 arrests, break-ins still soar. Boston Globe September 26, 2004: 12.
62. Harlow D. Drugs drive crime in central Maine. Dancesafe. Available at: http://www.mapinc.org/safe/v04/n1855/a05.html (accessed January 25, 2005).
63. McDonald M. Suspect held in rash of burglaries. Boston Globe December 5, 2004: 4.
64. Yakin H. Prescription-drug crimes on the rise. Times Herald-Record. Available at: http://www.recordonline.com/archive/2005/01/03/hyrx.htm (accessed January 28, 2005).
65. Weisel DL. Burglary of Single-Family Houses [Problem-Oriented Guides for Police Series, No. 18]. Washington, DC: U.S. Department of Justice, Office of Community Oriented Policing Services; 2004.
66. Wellsmith M, Burrell A. The influence of purchase price and ownership levels on theft targets: The example of domestic burglary. Br J Criminol 2005; 45(5): 741-64.
67. Sutton M. Supply by theft: Does the market for second-hand goods play a role in keeping crime figures high? Br J Criminol 1995; 35 (Summer): 400-16.
68. U.S. Drug Enforcement Administration. Drug Theft & Loss. Available at: http://www.aatod.org/pdfs/methadone-theft.pdf (accessed January 25, 2005).
69. U.S. Drug Enforcement Administration. OxyContin® Theft & Loss Incidents: January 2000 through June 2003. Washington, DC: U.S. Department of Justice. Available at: http://www.deadiversion.usdoj.gov/ drugs_concern/oxycodone/oxylosses_oct2003_1.pdf (accessed January 25, 2005).
70. Joranson DE, Gilson AM. Drug crime is a source of abused pain medications in the United States. J Pain Symptom Manage 2005; 30(4): 299-301.
71. Jesdanun A. Study: Few Americans Buy Drugs Online. New York: The Associated Press. Available at: LexisNexis Academic database (accessed October 10, 2004).
72. Bogart JG, Stevens SJ, Hill RJ, Estrada BD. Criminally involved drug-using mothers: The need for system change. Prison J 2005; 85(1): 65-82.
73. Logan TK, Leukefeld CG. Sexual and drug use behaviors among female crack users: A multi-site sample. Drug Alcohol Depend 2000; 58(3): 237-45.
74. Nyamathi AM, Stein JA, Bayley LJ. Predictors of mental distress and poor physical health among homeless women. Psychol Health 2000; 15(4): 483-500.
75. Roiser JP, Sahakian BJ. Relationship between ecstasy use and depression a study controlling poly-drug use. Psychopharmacology 2004; 173: 411-7.
76. Boyd CJ, McCabe SE, d'Arcy H. Ecstasy use among college undergraduates: Gender, race and sexual identity. J Subst Abuse Treat 2003; 24: 209-15.
77. Associated Press. AIDS drugs surface on black market. New York Times December 25, 1995; 1: 43.
78. Flaherty MP, Gaul GM. Florida Medicaid fraud costs millions, report says. Washington Post December 19, 2003; Financial: E03.
79. LaPadula P. Four arrested in Miami AIDS drug scheme: Defendants accused of selling drugs on the black market. Express Gay News 2005.
80. Crumplin G. EU reimporting drugs meant for Africa is only part of story. BMJ 2003; 326(7383): 285.
81. Medicines Australia. The fight against HIV/AIDS. Med Health 2002; 1(12): 1.
82. Klein A. Authorities shut down stolen medicines market with arrest of 17. Record September 10, 2004.
83. Dorschner J. Four arrested in AIDS drug scam. Miami Herald December 2, 2005: 1C.
84. Glasgow K. The new dealers: They're poor, Black, and HIV-positive. Their product? The AIDS medications intended to cure them. Miami New Times October 21, 1999.
85. Bell D. Bad Medicine: New York's Black Market in AIDS Drugs. Available at: http://www.citylimits.org/content/articles/ articleView.cfm?articlenumber=1264 (accessed December 6, 2006).
86. Wright K. Doin'the Hustle. POZ.com. Available at: http://www.blackaids.org/ShowArticle.aspx!articletype=NEWS&articleid= 87&pagenumber=1 (accessed April 21, 2006).
87. Windham C. Cracking down on illicit use of AIDS drugs. Wall Street Journal January 19, 2004: B1.
88. Bamberger JD, Unick J, Klein P, et al. Helping the urban poor stay with antiretroviral HIV drug therapy. Am J Public Health 2000; 90(5): 699-701.
89. Whitney N, Glazier R. Factors affecting medication adherence among the homeless: A qualitative study of patients' perspectives. Univ Toronto Med J 2004; 82(1): 6-9.
90. Dorschner J. Activists: HIV care scam uses homeless. Miami Herald June 30, 2005: 1A.